Year: 2022

ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the...

error: Content is protected !!